COMPLETE PHARMA HOLDINGS LLC (CP) (FORMERLY: MARATHON PHARMACEUTICALS, LLC) for COMPLETE PHARMA HOLDINGS LLC (CP) (FORMERLY: MARATHON PHARMACEUTICALS LLC)
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S. 289 - The American Cures Act, provisions related to investment in research and development H.R. 1537 - The Advancing Hope Act, provisions related to the Pediatric Rare Disease Priority Review Voucher Program Implementation of P.L. 113-166 - Muscular Dystrophy Cures Act Reintroduction of the Dormant Therapies Act The Pediatric Rare Disease Priority Review Voucher Program Precision Medicine and related activities Sale of Legacy Products Role of Marathon Pharmaceuticals, LLC as a rare disease company
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY ARONIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.